Decatur Capital Management, Inc. Abb Vie Inc. Transaction History

Decatur Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $6.27 Million - $7.36 Million	-73,029 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $440 - $589	6 Added 0.01%	73,029 $7.17 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $1.2 Million - $1.83 Million	-18,674 Reduced 20.36%	73,023 $5.56 Million
Q4 2019 Jan 21, 2020	SELL	$72.13 - $90.25 $86,411 - $108,119	-1,198 Reduced 1.29%	91,697 $8.12 Million
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $2.27 Million - $2.73 Million	-36,025 Reduced 27.94%	92,895 $7.03 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $187,179 - $239,259	-2,849 Reduced 2.16%	128,920 $9.38 Million
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $10.2 Million - $12 Million	131,769 New	131,769 $10.6 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.